N/A
Completed N=50,343
Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs
Source: ClinicalTrials.gov NCT00461253 ↗Enrolled (actual)
50,343
Serious AEs
20.6%
Results posted
Jan 2016
Primary outcomePrimary: Breast Cancer Risk — 1076; 1068 participants
Summary
The objective of this study is to determine the breast cancer risk of Mirena® users compared to copper intrauterine device (IUD) users in a community-based case-control study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Breast Cancer Risk |
1076; 1068 | — |
Eligibility Criteria
Inclusion Criteria
- cases: women with a breast cancer who are younger than 50 years of age at cancer diagnosis
- controls: women without a breast cancer diagnosis who are younger than 50 years at the time of the interview
Exclusion Criteria
- women who are not willing to participate
Data sourced from ClinicalTrials.gov (NCT00461253). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.